SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022936
Filing Date
2020-05-07
Accepted
2020-05-07 16:36:49
Documents
75
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20200331.htm 10-Q 1370222
2 EX-10.1 vtvt-ex101_183.htm EX-10.1 73931
3 EX-31.1 vtvt-ex311_10.htm EX-31.1 17629
4 EX-31.2 vtvt-ex312_6.htm EX-31.2 17519
5 EX-32.1 vtvt-ex321_7.htm EX-32.1 7257
6 EX-32.2 vtvt-ex322_11.htm EX-32.2 7214
7 GRAPHIC g1ij3kdt2wp3000001.jpg GRAPHIC 30075
  Complete submission text file 0001564590-20-022936.txt   5876161

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vtvt-20200331.xml EX-101.INS 1146307
9 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20200331.xsd EX-101.SCH 59304
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20200331_cal.xml EX-101.CAL 45766
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20200331_def.xml EX-101.DEF 232677
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20200331_lab.xml EX-101.LAB 412228
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20200331_pre.xml EX-101.PRE 329316
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 20857064
SIC: 2834 Pharmaceutical Preparations